A new antimicrobial promises a solution for respiratory disease in cattle. Zoetis says its ADVOCIN® (danofloxacin mesylate) Sterile Injectable Solution is an effective control mechanism against bovine respiratory disease (BRD) in high-risk cattle.

ADVOCIN offers a convenient alternative for veterinarians and producers managing BRD. Producers can now use ADVOCIN for control of BRD in high-risk cattle on arrival or take advantage of the short, four-day withdrawal time for treating respiratory disease late in the feeding period. ADVOCIN delivers what veterinarians expect from a fluoroquinolone and now offers added flexibility to use the product in two ways.

“The new ADVOCIN claim helps provide another way to control BRD with the fast-acting fluoroquinolone power of ADVOCIN,” said Jeffrey Sarchet, DVM, Beef Technical Services, Zoetis. “BRD remains one of the most economically impactful challenges facing the beef industry and is extremely difficult to diagnose. Choosing the right antimicrobials that help control and treat subclinical BRD is critical to cattle health, performance and the bottom line of any operation.”

Zoetis officials say ADVOCIN is part of a comprehensive and versatile portfolio of leading BRD management solutions, including DRAXXIN® (tulathromycin) Injectable Solution and EXCEDE® (ceftiofur crystalline free acid) Sterile Suspension.